Viewing Study NCT01661868


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-27 @ 11:47 PM
Study NCT ID: NCT01661868
Status: WITHDRAWN
Last Update Posted: 2012-08-21
First Post: 2011-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module